Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.22.2
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Adjusted balance
Common Stock
Common Stock
Adjusted balance
Additional Paid-in Capital
Additional Paid-in Capital
Adjusted balance
Other Comprehensive Income
Other Comprehensive Income
Adjusted balance
Accumulated Deficit
Accumulated Deficit
Adjusted balance
Balance at beginning of period at Dec. 31, 2020   $ (32,813)   $ 3   $ 191,168   $ 0   $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020       34,692,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation $ 508       $ 508          
Issuance of common stock due to Bridge Notes 103,724   $ 2   103,722          
Issuance of common stock due to Bridge Notes (in shares)     20,029,000              
Issuance of common stock upon exercise of stock options (in shares)     468,000              
Issuance of common stock upon exercise of stock options 1       1          
Issuance of common stock upon vesting of restricted stock awards (in shares)     171,000              
Issuance of common stock on conversion (in shares)     1,095,000              
Issuance of common stock on conversion 120       120          
Other comprehensive income (loss) 1,389           $ 1,389      
Net loss (168,556)               $ (168,556)  
Balance at end of period at Mar. 31, 2021 (95,627)   $ 5   295,519   1,389   (392,540)  
Balance at end of period (in shares) at Mar. 31, 2021     56,455,000              
Balance at beginning of period at Dec. 31, 2020   $ (32,813)   $ 3   $ 191,168   $ 0   $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020       34,692,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Other comprehensive income (loss) (541)                  
Net loss (204,141)                  
Balance at end of period at Jun. 30, 2021 (130,243)   $ 5   298,418   (541)   (428,125)  
Balance at end of period (in shares) at Jun. 30, 2021     57,143,000              
Balance at beginning of period at Mar. 31, 2021 (95,627)   $ 5   295,519   1,389   (392,540)  
Balance at beginning of period (in shares) at Mar. 31, 2021     56,455,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation 264       264          
Issuance of common stock due to Bridge Notes Rights Offering 2,629       2,629          
Issuance of common stock due to rights offering (in shares)     314,000              
Issuance of common stock upon exercise of stock options (in shares)     210,000              
Issuance of common stock upon exercise of stock options 6       6          
Issuance of common stock upon vesting of restricted stock awards (in shares)     130,000              
Issuance of common stock upon vesting of restricted stock units (in shares)     34,000              
Other comprehensive income (loss) (1,930)           (1,930)      
Net loss (35,585)               (35,585)  
Balance at end of period at Jun. 30, 2021 (130,243)   $ 5   298,418   (541)   (428,125)  
Balance at end of period (in shares) at Jun. 30, 2021     57,143,000              
Balance at beginning of period at Dec. 31, 2021 $ 179,620   $ 11   650,518   0   (470,909)  
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452,000   114,452,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation $ 10,862       10,862          
Issuance of common stock upon exercise of stock options (in shares)     404,000              
Issuance of common stock upon exercise of stock options 17       17          
Issuance of common stock upon vesting of restricted stock awards (in shares)     129,000              
Issuance of common stock upon vesting of restricted stock units (in shares)     4,816,000              
Issuance of common stock upon vesting of restricted stock units 1   $ 1              
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)     1,874,000              
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units (3,616)       (3,616)          
Net loss (19,988)               (19,988)  
Balance at end of period at Mar. 31, 2022 166,896   $ 12   657,781   0   (490,897)  
Balance at end of period (in shares) at Mar. 31, 2022     117,927,000              
Balance at beginning of period at Dec. 31, 2021 $ 179,620   $ 11   650,518   0   (470,909)  
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452,000   114,452,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares) 584,000                  
Other comprehensive income (loss) $ 0                  
Net loss (46,266)                  
Balance at end of period at Jun. 30, 2022 $ 143,547   $ 12   660,710   0   (517,175)  
Balance at end of period (in shares) at Jun. 30, 2022 118,453,000   118,453,000              
Balance at beginning of period at Mar. 31, 2022 $ 166,896   $ 12   657,781   0   (490,897)  
Balance at beginning of period (in shares) at Mar. 31, 2022     117,927,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock-based compensation 3,365       3,365          
Issuance of common stock upon exercise of stock options (in shares)     180,000              
Issuance of common stock upon exercise of stock options 8       8          
Issuance of common stock upon vesting of restricted stock awards (in shares)     27,000              
Issuance of common stock upon vesting of restricted stock units (in shares)     520,000              
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)     201,000              
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units (444)       (444)          
Other comprehensive income (loss) 0                  
Net loss (26,278)               (26,278)  
Balance at end of period at Jun. 30, 2022 $ 143,547   $ 12   $ 660,710   $ 0   $ (517,175)  
Balance at end of period (in shares) at Jun. 30, 2022 118,453,000   118,453,000